Cocaine mutagenicity and hepatocarcinogenicity evaluations in rodents

Teratogenesis Carcinogenesis and Mutagenesis

Volumn 18, Issue 4, 1998, Pages 199-208

  Favero Salvadori, Daisy Maria ^a   Barbisan, Luis Fernando ^a   Bazo, Ana Paula ^a   De Santana, Efigênia Queiroz ^b   Denadai, Roberta ^a   De Oliveira, Susie Vieira ^a,c   Ribeiro, Lúcia Regina ^a   Viana De Camargo, João Lauro ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b Departamento de Nutrifarma   (Brazil)

^c DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

Author keywords

Cocaine; Micronucleus test; Mouse bone marrow; Rat liver carcinogenesis bioassay

Indexed keywords

COCAINE; DIMETHYLNITROSAMINE; GLUTATHIONE TRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ASSAY; GROWTH REGULATION; LIVER CARCINOGENESIS; MICRONUCLEUS TEST; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR GROWTH;

ANIMALS; BONE MARROW; COCAINE; GLUTATHIONE TRANSFERASE; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICRONUCLEUS TESTS; MUTAGENS; RATS; RATS, WISTAR;

ANIMALIA; NICOTIANA TABACUM; RODENTIA;

EID: 7844235806     PISSN: 02703211     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6866(1998)18:4<199::AID-TCM5>3.0.CO;2-S     Document Type: Article

References (34)

1. Kloss MW, Rosen GM, Rauckman EJ: Cocaine mediated hepatotoxicity. Biochem Pharmacol 33:169-173, 1984.
2. Dattel BJ: Substance abuse in pregnancy. Semin Perinatol 14:179-187, 1990.
3. Mahalik MP, Gautieri RF, Mann DE: Teratogenic potential of cocaine hydrochloride in CF-1 mice. J Pharmacol Sci 69:703-706, 1980.
4. Church MW, Dincheff BA, Gessner PK: Dose-dependent consequences of cocaine on pregnancy outcome in the Long-Evans rat. Neurotoxicol Teratol 10:51-58, 1988.
5. Bingol N, Fuchs M, Diaz V, Stone RK, Gromisch DS: Teratogenicity of cocaine in humans. J Pediatr 110:93-96, 1987.
6. Rizk B, Atterbury JL, Groome LJ: Reproductive risks of cocaine. Hum Reprod Update 2:43-55, 1996.
7. Boelsterli UA, Wolf A, Goldlin C: Oxygen free radical production mediated by cocaine and its ethanol-derived metabolite in rat hepatocytes. Hepatology 18:1154-1161, 1993.
8. Decailleaux J, Rodriguez LA, Paredes M, Abarca M: El consumo de pasta basica de cocaína (PBC) incrementa la frecuencia de intercambio de cromatides humanas. In "Proceedings of the First Latin American Symposium on Environmental Mutagenesis." Alamcta Caxambú, Brazil: 1991, 53.
9. Rosenkranz HS, Klopman G: The carcinogenic potential of cocaine. Cancer Lett 52:243-246, 1990.
10. Ito N, Shirai T, Hasegawa R: Medium-term bioassay for carcinogens. In Vanio H, Magee PN, MacGregor DB, McMichael AJ: "Mechanisms of Carcinogenesis in Risk Identification." Lyon: IARC, 1992, 353-388.
11. Ito N, Hasegawa R, Imaida K, Hirose M, Shirai T: Medium-term liver and multi-organ carcinogenesis bioassays for carcinogens and chemopreventive agents. Exp Toxicol Pathol 48:113-119, 1996.
12. Hasegawa R, Ito N: Liver medium-term bioassay in rats for screening of carcinogens and modifying factors in hepatocarcinogenesis. Food Chem Toxicol 30:979-992, 1992.
13. Ito N, Tsuda H, Tatematsu M, Inoue T, Tagawa Y, Aoki T, Uwagawa S, Kagawa M, Ogiso T, Masui T, Imaida K, Fukushima S, Asamoto M: Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats: an approach for a new medium-term bioassay system. Carcinogenesis 9:387-394, 1988.
14. 50) and instruction in their use. Biometrics 8:249-263, 1952.
15. MacGregor JT, Heddle JA, Hite M, Margolin BH, Ramel C, Salamone MF, Tia RR, Wild D: Guidelines for the conduct of micronucleus assay in mammalian bone marrow erythrocytes. Mutat Res 189:103-112, 1987.
16. The Merck Index: "An Encyclopedia of Chemicals, Drugs, and Biologicals." Rahway, NJ: Merck & Co., Inc., 1989, 2451.
17. Dragan YP, Hully J, Crow R, Mass M, Pitot HC: Incorporation of bromodeoxyuridine in glutathione S-transferase-positive hepatocytes during rat multistage hepatocarcinogenesis. Carcinogenesis 15:1939-1947, 1994.
18. Snedecor GM, Cochran WS: "Statistical Methods." Ames, IA: Iowa University, 1980.
19. Ashby J, Walters MD, Preston J, Adler ID, Douglas GR, Fielder R, Shelby MD, Anderson D, Sofuni T, Gopalan HNB, Becking G, Sonich-Mullin C: IPCS harmonization of methods for the prediction and quantification of human carcinogenic/mutagenic hazard, and for indicating the probable mechanisms of action of carcinogens. Mutat Res 352:153-157, 1996.
20. Mavournin KH, Blakey DH, Cimino MC: The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res 239:239, 1990.
21. Boelsterli UA, Goldlin C: Biomechanisms of cocaine-induced hepatocyte injury mediated by the formation reactive metabolites. Arch Toxicol 65:351-360, 1991.
22. Evans MA, Harbison RD: Cocaine-induced hepatic necrosis in mice. Toxicol Appl Pharmacol 45:739-745, 1978.
23. Freeman RW, Harbison RD: Hepatic periportal necrosis induced by chronic administration of cocaine. Biochem Pharmacol 30:777-783, 1981.
24. Mehanny SZ, Abdel-Rahman MS: Cocaine hepatotoxicity in mice: Histologic and enzymatic studies. Toxicol Pathol 19:24-29, 1991.
25. Cascales M, Alvarez A, Gascó P, Fernández-Simón L, Sanz N, Boscá L: Cocaine-induced injury in mouse elicits specific changes in DNA ploidy and induces programmed death of hepatocytes. Hepatology 20:992-1001, 1994.
26. Perino LE, Warren GH, Levine JS: Cocaine-induced hepatotoxicity in humans. Gastroenterology 93:176-180, 1987.
27. Silva MO, Roth D, Reddy KR, Fernandez JA, Albores-Saavedra J, Schiff ER: Hepatic disfunction accompanying cocaine intoxication. J Hepatol 12:312-315, 1991.
28. Donnelly DA, Boyer CS, Petersen DR, Ross D: Cocaine-induced biochemical changes and cytotoxicity in hepatocytes isolated from both mice and rats. Chem Biol Interact 67:95-104, 1988.
29. Roberts SM, Pounds JG, James RC: Cocaine toxicity in cultured rat hepatocytes. Toxicol Lett 50:283-288, 1990.
30. Ward JM, Tsuda H, Tatematsu M, Hagiwara A, Ito N: Hepatotoxicity of agents that enhance formation of focal hepatocellular proliferative lesions (putative preneoplastic foci) in a rapid rat liver bioassay. Fund Appl Toxicol 12:163-171, 1988.
31. Cohen SM, Ellwein LB: Cell proliferation and carcinogenesis. Science 249:1007-1011, 1990.
32. Rao SM, Reddy JK: An overview of peroxisome proliferation-induced hepatocarcinogenesis. Environ Health Perspect 93:205-209, 1991.
33. Rao SM, Nemali MR, Usuda N, Scarpelli DG, Makino T, Pitot HC, Reddy JK: Lack of expression of glutathione S-transferase P, γ-glutamyl transpeptidase, and alpha-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators. Cancer Res 48:4919-4925, 1988.
34. Maekawa M, Onodera H, Ogasawara H, Matsushira Y, Mitsumori K, Hayashi Y: Threshold dose dependence in phenobarbital promotion of rat hepatocarcinogenesis initiated by diethylnitrosamine. Carcinogenesis 13:501-523, 1993.